Publicaciones
El conocimiento generado en IrsiCaixa se comparte con la comunidad científica a través de la publicación de artículos en revistas científicas de alto impacto.
Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection.
Mechanistic basis of zidovudine hypersusceptibility and lamivudine resistance conferred by the deletion of codon 69 in the HIV-1 reverse transcriptase coding region.
Drug-resistance mutations number and K70R or T215Y/F substitutions predict treatment resumption during guided treatment interruptions.
Prevalence of etravirine-associated mutations in clinical samples with resistance to nevirapine and efavirenz.
HIV-1 protease catalytic efficiency effects caused by random single amino acid substitutions.
Genetic and catalytic efficiency structure of an HCV protease quasispecies.
Antiretroviral therapy interruption guided by CD4 cell counts and plasma HIV-1 RNA levels in chronically HIV-1-infected patients.
Clinical approach to drug resistance interpretation: expert advice.
Combination of a mutagenic agent with a reverse transcriptase inhibitor results in systematic inhibition of HIV-1 infection.
Alternation of antiretroviral drug regimens for HIV infection. Efficacy, safety and tolerability at week 96 of the Swatch Study.